Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Nov;97(5):686-688.
doi: 10.1111/cen.14539. Epub 2021 Jul 12.

MRI follow-up of patients with acromegaly being treated with first-generation somatostatin receptor ligands after surgery

Naia Grandgeorge  1 , Giovanni Barchetti  2 , Solange Grunenwald  1 , Fabrice Bonneville  2 , Philippe Caron  1
Affiliations
Comment

MRI follow-up of patients with acromegaly being treated with first-generation somatostatin receptor ligands after surgery

Naia Grandgeorge et al. Clin Endocrinol (Oxf). 2022 Nov.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Katznelson L, Laws ER Jr., Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014;99(11):3933-3951. https://doi.org/10.1210/jc.2014-2700
    1. Melmed S, Bronstein MD, Chanson P, et al. A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol. 2018;14(9):552-561. https://doi.org/10.1038/s41574-018-0058-5
    1. Starnoni D, Daniel RT, Marino L, Pitteloud N, Levivier M, Messerer M. Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis. Acta Neurochir. 2016;158(11):2109-2121. https://doi.org/10.1007/s00701-016-2903-4
    1. Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ. Octreotide. N Engl J Med. 1996;334(4):246-254. https://doi.org/10.1056/NEJM199601253340408
    1. Cozzi R, Montini M, Attanasio R, et al. Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. J Clin Endocrinol Metab. 2006;91(4):1397-1403. https://doi.org/10.1210/jc.2005-2347

LinkOut - more resources